rxstat › Shortages › Buserelin
Buserelin shortage status
Widespread shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Buserelin is in a widespread shortage in Canada. 2 of 4 reported products are affected. Manufacturers have not committed to a recovery date.
In shortage since
Oct 24, 2023
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageSUPREFACT DEPOT 2 MONTHS
6.3MG · IMPLANT · CHEPLAPHARM ARZNEIMITTEL GMBH
DIN 02228955 · since Nov 1, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortageSUPREFACT DEPOT 3 MONTHS
9.45MG · IMPLANT · CHEPLAPHARM ARZNEIMITTEL GMBH
DIN 02240749 · since Oct 24, 2023, no end estimate · Disruption of the manufacture of the drug.
reversedSUPREFACT DEPOT 3 MONTHS
9.45MG · IMPLANT · CHEPLAPHARM ARZNEIMITTEL GMBH
DIN 02240749
ResolvedSUPREFACT
1MG · SOLUTION · CHEPLAPHARM ARZNEIMITTEL GMBH
DIN 02225166 · ended Jun 28, 2024 · Disruption of the manufacture of the drug.
reversedSUPREFACT DEPOT 2 MONTHS
6.3MG · IMPLANT · CHEPLAPHARM ARZNEIMITTEL GMBH
DIN 02228955
ResolvedSUPREFACT DEPOT 3 MONTHS
9.45MG · IMPLANT · CHEPLAPHARM ARZNEIMITTEL GMBH
DIN 02240749 · ended May 16, 2024 · Disruption of the manufacture of the drug.
ResolvedSUPREFACT
1MG · SOLUTION · CHEPLAPHARM ARZNEIMITTEL GMBH
DIN 02225166 · ended Dec 7, 2022 · Delay in shipping of the drug.
ResolvedSUPREFACT
1MG · SOLUTION · CHEPLAPHARM ARZNEIMITTEL GMBH
DIN 02225166 · ended May 24, 2022 · Delay in shipping of the drug.
ResolvedSUPREFACT
1MG · SOLUTION · CHEPLAPHARM ARZNEIMITTEL GMBH
DIN 02225166 · ended Dec 31, 2021 · Delay in shipping of the drug.
DiscontinuedSUPREFACT
100MCG · SOLUTION · CHEPLAPHARM ARZNEIMITTEL GMBH
DIN 02225158
ResolvedSUPREFACT
1MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02225166 · ended Feb 18, 2020 · Other (Please describe in comments)
ResolvedSUPREFACT
1MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02225158 · ended Jun 3, 2019 · Other (Please describe in comments)
Showing 12 of 13 reports. All reports are on file with Health Canada.
What's happening
Buserelin is currently affected by 2 active shortage reports filed with Health Canada by CHEPLAPHARM ARZNEIMITTEL GMBH.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Buserelin is classified under “HORMONES AND RELATED AGENTS” (ATC L02AE).
Recent changes
Common questions
When will Buserelin be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Buserelin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
All hormones and related agents shortage statuses →
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.